Non Small Cell Lung Cancer

Showing NaN - NaN of 39

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

PET-CT Predicting Segement Specific Lymph Nodes Metastasis

Recruiting
  • Non Small Cell Lung Cancer
  • +2 more
    • Shanghai, China
      Shanghai Cancer Center
    Jul 23, 2023

    Non Small Cell Lung Cancer Trial in China (TQB2450 injection + Chemotherapy, TQB2450 injection + Anlotinib Hydrochloride

    Recruiting
    • Non Small Cell Lung Cancer
    • TQB2450 injection + Chemotherapy
    • TQB2450 injection + Anlotinib Hydrochloride Capsule
    • Beijing, Beijing, China
    • +9 more
    Jun 27, 2023

    Non Small Cell Lung Cancer Trial in Worldwide (Telisotuzumab Vedotin, Docetaxel)

    Recruiting
    • Non Small Cell Lung Cancer
    • Los Angeles, California
    • +212 more
    Jan 26, 2023

    Non Small Cell Lung Cancer Trial in Shanghai (CS1001 mAb, CS1001 )

    Active, not recruiting
    • Non Small Cell Lung Cancer
    • CS1001 monoclonal antibody
    • CS1001 placebo
    • Shanghai, Shanghai, China
      Shanghai Pulmonary Hospital
    Nov 8, 2022

    Non Small Cell Lung Cancer Trial in Worldwide (Telisotuzumab Vedotin)

    Not yet recruiting
    • Non Small Cell Lung Cancer
    • Telisotuzumab Vedotin
    • Clayton, Victoria, Australia
    • +54 more
    Aug 23, 2022

    Resectable Non-Small Cell Lung Cancer Stages IIB-IIIB

    Recruiting
    • Non Small Cell Lung Cancer
    • anti-PD-1 or anti-PD-L1
    • +2 more
    • Shanghai, China
      Oncology Department, Shanghai Chest Hospital
    Jul 26, 2022

    Non Small Cell Lung Cancer Trial in Shanghai (HS-10241)

    Recruiting
    • Non Small Cell Lung Cancer
    • Shanghai, Shanghai, China
      Shanghai Chest Hospital
    Jun 19, 2022

    Non Small Cell Lung Cancer Trial in Worldwide (Nivolumab, Cisplatin, Vinorelbine)

    Active, not recruiting
    • Non Small Cell Lung Cancer
    • Nivolumab
    • +8 more
    • Glendale, Arizona
    • +135 more
    Feb 28, 2022

    Non Small Cell Lung Cancer Trial in China (Tislelizumab, Cisplatin injection, Paclitaxel injection)

    Recruiting
    • Non Small Cell Lung Cancer
    • Hefei, Anhui, China
    • +47 more
    Jan 24, 2022

    Non Small Cell Lung Cancer Trial in China (Chidamide, Envafolimab)

    Recruiting
    • Non Small Cell Lung Cancer
    • Hefei, Anhui, China
    • +11 more
    Jan 17, 2022

    Non Small Cell Lung Cancer Trial in Shanghai (Trametinib, Anlotinib)

    Recruiting
    • Non Small Cell Lung Cancer
    • Shanghai, Shanghai, China
      Shanghai Chest Hospital
    Jan 16, 2022

    Sarcopenia and Nutritional Status in Early-stage Non-small Cell

    Not yet recruiting
    • Sarcopenia
    • +2 more
    • Inbody 570
    • +2 more
    • Shanghai, Shanghai, China
      Huadong hospital, Fudan University
    Jan 27, 2022

    Non Small Cell Lung Cancer Trial in Shanghai (RC48)

    Active, not recruiting
    • Non Small Cell Lung Cancer
    • Shanghai, Shanghai, China
      Shanghai Pulmonary Hospital
    Jan 26, 2022

    Non Small Cell Lung Cancer Trial in Shanghai (Tislelizumab, Carboplatin, Pemetrexed)

    Recruiting
    • Non Small Cell Lung Cancer
    • Shanghai, Shanghai, China
      Shanghai Chest Hospital
    Nov 19, 2021

    Non Small Cell Lung Cancer Trial in China (TQB2450 injection, Anlotinib Hydrochloride Capsules, Pembrolizumab injection)

    Recruiting
    • Non Small Cell Lung Cancer
    • TQB2450 injection
    • +3 more
    • Beijing, Beijing, China
    • +16 more
    Aug 18, 2021

    Identify Prognostic Biomarkers of Lung Cancer

    Recruiting
    • Lung Cancer
    • +3 more
      • Shanghai, China
        Renji Hospital, Shanghai Jiaotong University school of medicine
      Aug 14, 2021

      Non Small Cell Lung Cancer Trial in Shanghai (AB-106)

      Recruiting
      • Non Small Cell Lung Cancer
      • Shanghai, Shanghai, China
        Shanghai Pulmonary Hospital
      Jun 17, 2021

      Non Small Cell Lung Cancer, ROS1 Proto Oncogene, Crizotinib Trial in Worldwide (Crizotinib)

      Completed
      • Non Small Cell Lung Cancer
      • +2 more
      • Hefei, Anhui, China
      • +43 more
      Feb 3, 2021

      Non Small Cell Lung Cancer Trial in Shanghai (Durvalumab Anlotinib Carboplatin Nab-paclitaxel)

      Recruiting
      • Non Small Cell Lung Cancer
      • Durvalumab Anlotinib Carboplatin Nab-paclitaxel
      • Shanghai, Shanghai, China
        Shanghai Pulmonary Hospital
      Feb 17, 2021

      Non Small Cell Lung Cancer Trial in China (Carboplatin, Pemetrexed or Nab-paclitaxel, PD-1 antibody)

      Recruiting
      • Non Small Cell Lung Cancer
      • Lanzhou, Gansu, China
      • +7 more
      Feb 18, 2021

      Non Small Cell Lung Cancer Trial in China (TQ-B3139)

      Recruiting
      • Non Small Cell Lung Cancer
      • Hefei, Anhui, China
      • +15 more
      Sep 10, 2020

      Inactivated Trivalent Influenza Vaccine on NSCLC Patients

      Not yet recruiting
      • Non Small Cell Lung Cancer
      • Influenza Vaccine
      • PD-1/PD-L1 inhibitors
      • Inactivated trivalent influenza vaccine
      • Hong Kong, Hong Kong, China
      • +1 more
      Apr 20, 2020

      Non Small Cell Lung Cancer Trial in Shanghai (radiochemo 1, radiochemo 2, radiochemo 3)

      Completed
      • Non Small Cell Lung Cancer
      • radiochemotherapy 1
      • +6 more
      • Shanghai, China
        the Ethic Committee of Shanghai General Hospital
      May 1, 2019

      Non Small Cell Lung Cancer Trial in Shanghai (Mitochondria-targeted System Therapy Combined With Radiofrequency Ablation,

      Recruiting
      • Non Small Cell Lung Cancer
      • Mitochondria-targeted System Therapy Combined With Radiofrequency Ablation
      • Surgery
      • Shanghai, Shanghai, China
        Shanghai 10th People's Hospital
      Feb 18, 2019

      Non Small Cell Lung Cancer, Breast Cancer Trial in China (YPEG-rhG-CSF, 20µg/kg, single s.c. at 48hrs after chemo for each

      Completed
      • Non Small Cell Lung Cancer
      • Breast Cancer
      • YPEG-rhG-CSF, 20μg/kg, single s.c. at 48hrs after chemotherapy for each experimental cycle
      • +3 more
      • Zhangzhou, Fujian, China
      • +11 more
      Jul 15, 2018